Molecular genetic alterations in ductal pancreatic adenocarcinomas

Medical Clinics of North America

Volumn 84, Issue 3, 2000, Pages 691-695

  Kern, Scott E ^b  

^a Ross Research Building   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

CANCER SUSCEPTIBILITY; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; ONCOGENE; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0034094977     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70251-0     Document Type: Article

References (31)

1. C. Almoguerra D. Shibata K. Forrester Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes Cell 53 1988 549
2. C. Caldas S.A. Hahn da Costa L.T. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma Nat Genet 8 1994 27
3. J.Q. Cheng B. Ruggeri W.M. Klein Amplification of AKT2 in human pancreatic cancer cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA Proc Natl Acad Sci U S A 93 1996 3636
4. A.L. Cubilla P.J. Fitzgerald Morphological lesions associated with human primary invasive nonendocrine pancreas cancer Cancer Res 36 1976 2690
5. B.M. Ghadimi E. Schröck R.L. Walker Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas Am J Pathol 154 1999 525
6. F.M. Giardiello S.B. Welsh S.R. Hamilton Increased risk of cancer in the Peutz-Jeghers syndrome N Engl J Med 316 1987 1511
7. M. Goggins G.J.A. Offerhaus W. Hilgers Adenocarcinomas of the pancreas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology: Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+ Am J Pathol 152 1998 1501
8. M. Goggins M. Schutte J. Lu Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas Cancer Res 56 1996 5360
9. M. Goggins M. Shekher K. Turnacioglu Genetic alterations of the TGFβ receptor genes in pancreatic and biliary adenocarcinomas Cancer Res 58 1998 5329
10. C.A. Griffin R.H. Hruban L.A. Morsberger Consistent chromosome abnormalities in adenocarcinoma of the pancreas Cancer Res 55 1995 2394
11. S.A. Hahn M. Schutte A.T.M.S. Hoque DPC4, a candidate tumor-suppressor gene at 18q21.1 Science 271 1996 350
12. L. Huang D. Lang J. Geradts Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines Mol Carcinog 15 1996 85
13. B. Johansson G. Bardi S. Heim Nonrandom chromosomal rearrangements in pancreatic carcinomas Cancer 69 1992 1
14. S. Kozuka R. Sassa T. Taki Relation of pancreatic duct hyperplasia to carcinoma Cancer 43 1979 1418
15. J.M. Lancaster R. Wooster J. Mangion BRCA2 mutations in primary breast and ovarian cancers Nat Genet 13 1996 238
16. A.B. Lowenfels P. Maisonneuve E.P. DiMagno Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group J Natl Cancer Inst 89 1997 442
17. C.A. Moskaluk R.H. Hruban S.E. Kern p16 and K-ras mutations in the intraductal precursors of human pancreatic adenocarcinoma Cancer Res 57 1997 2140
18. H. Ozcelik B. Schmocker Di Nocala N. Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients Nat Genet 16 1997 17
19. S. Pellegata F. Sessa B. Renault K-ras and p53 gene mutations in pancreatic cancer: Ductal and nonductal tumors progress through different genetic lesions Cancer Res 54 1994 1556
20. M.S. Redston N. Papadopoulos C. Caldas Common occurrence of APC and K-RAS gene mutations in the spectrum of colitis-associated neoplasias Gastroenterology 108 1995 383
21. E. Rozenblum M. Schutte M. Goggins Tumor-suppressive pathways in pancreatic carcinoma Cancer Res 57 1997 1731
22. Schutte M. da Costa L.T. S.A. Hahn A homozygous deletion identified by representational difference analysis in pancreatic carcinoma overlaps the BRCA2 region Proc Natl Acad Sci U S A 92 1995 5950
23. S. Sommer S.A. Murphy S. Warren Pancreatic duct hyperplasia and cancer Gastroenterology 27 1954 629
24. G.H. Su W. Hilgers M. Shekher Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor-suppressor gene Cancer Res 58 1998 2339
25. G.H. Su R.H. Hruban G.S. Bova Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers Am J Pathol 154 1999 1835
26. H. Takahashi H.C. Chiu C.A. Bandera Mutations of the BRCA2 gene in ovarian carcinomas Cancer Res 56 1996 2738
27. Teng D.H.F. Perry W.L. III J.K. Hogan Human mitogen-activated protein kinase 4 as a candidate tumor suppressor Cancer Res 57 1997 4177
28. S. Thorlacius G. Olafsdottir L. Tryggvadottir A single BRCA2 mutation in male and female breast carcinoma families from Iceland with varied cancer phenotypes Nat Genet 13 1996 117
29. C. Wallrapp F. Muller-Pillasch S. Solinas-Toldo Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-MYB as a candidate oncogene Cancer Res 57 1997 3135
30. D.C. Whitcomb M.C. Gorry R.A. Preston Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene Nat Genet 14 1996 141
31. R. Wooster G. Bignell J. Lancaster Identification of the breast cancer susceptibility gene BRCA2 Nature 378 1995 789